Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
American Journal of Cancer Research|June 9, 2023
N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancerMengyuan Cai, Chuang Yang, Zhonglin Wang
Heliyon|January 31, 2024
Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunityMengyuan Cai, Jianyi Zhao, Qiang Ding, et al.
European Journal of Pharmacology|August 30, 2025
Multifaceted safety concerns of glibenclamide in managing type 2 diabetes: Evidence from real-world adverse event analysisMengyuan Cai, Yujie Li, Mixue Guo, et al.
BMC Cancer|June 7, 2026
Pharmacovigilance of carmustine: distinct neurotoxic and systemic safety signals identified in FAERSKaizhi Xu, Meixuan Guo, Huqiang Dong, et al.
European Journal of Pharmacology|August 20, 2025
Post-marketing safety profile of Ertugliflozin: Insights from a real-world pharmacovigilance analysis based on the FAERS databaseHuqiang Dong, Qian Guo, Mengyuan Cai, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 26, 2026
Musculoskeletal adverse events with incretin-based diabetes drugs: a FAERS pharmacovigilance studyMeixuan Guo, Si Chen, Huqiang Dong, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 4, 2026
Comprehensive Pharmacovigilance Assessment of Pegvisomant-Associated Adverse Events Using the FAERS and WHO VigiAccess DatabasesKaizhi Xu, Qian Guo, Mengyuan Cai, et al.
Pageof 3